Dynamic Technology Lab Private LTD Acelrx Pharmaceuticals Inc Transaction History

Dynamic Technology Lab Private LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$2.6 - $4.6 $39,280 - $69,496	-15,108 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$2.13 - $4.2 $32,180 - $63,453	15,108 New	15,108 $51,000
Q4 2017 Feb 09, 2018	SELL	$1.75 - $5.5 $40,941 - $128,672	-23,395 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$2.9 - $4.6 $67,845 - $107,616	23,395	23,395 $108,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.